Skip to content

Upstream Bio, Inc. UPB Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$266.8M+13.8%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1.99M-20.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$13.61K-99.9%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$328K-59.1%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.38M+29.5%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$10.95M-6.3%

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Upstream Bio, Inc.’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s operating lease liabilities (total)?
Upstream Bio, Inc. (UPB) reported operating lease liabilities (total) of $1.27M in Q4 2025.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.